Lenalidomide (Revlimid), in combination with cyclophosphamide and dexamethasone (RCD), is an effective and tolerated regimen for myeloma patients (Q80097758)
Jump to navigation
Jump to search
scientific article published on 01 May 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Lenalidomide (Revlimid), in combination with cyclophosphamide and dexamethasone (RCD), is an effective and tolerated regimen for myeloma patients |
scientific article published on 01 May 2007 |
Statements
Lenalidomide (Revlimid), in combination with cyclophosphamide and dexamethasone (RCD), is an effective and tolerated regimen for myeloma patients (English)
Stephen A Schey
Ping Wu
Muralikrishan Srikanth
Karen J Phekoo
Faith E Davies